Mark O Hatfield-Warren Grant Magnusun Clinical Center

Bethesda, Maryland 20892

0 studies enrolling now · 1 studies all time

What they study most

Refractory or Recurrent Solid Tumors, Excluding CNS Tumors

Studies at this site

• VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors — Completed